OABI · NASDAQ · Biotechnology

OmniAb (OABI)

Provides antibody-discovery technologies that feed partner drug programs and royalty economics.

$4.94
After hours+0.02 (+0.44%)
At close$4.92(+7.42%)
  1. OmniAb Raises 2026 Financial Guidance

    Business WireGuidance